New Zealand markets closed

OCGN Jan 2023 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.90000.0000 (0.00%)
As of 03:59PM EDT. Market open.
Full screen
Previous close0.9000
Open0.9000
Bid0.8000
Ask1.1900
Strike2.50
Expiry date2023-01-20
Day's range0.9000 - 0.9300
Contract rangeN/A
Volume17
Open interest3.4k
  • Motley Fool

    1 Robinhood Stock to Avoid Right Now

    Commission-free trading platform Robinhood Markets grew in prominence helping newer investors participate in what remains one of the best ways to accumulate wealth over time. One example is Ocugen (NASDAQ: OCGN). Can Ocugen succeed in the COVID-19 vaccine market?

  • GlobeNewswire

    Ocugen CEO to Present at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

    MALVERN, Pa., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will deliver a virtual presentation at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17. A video webcast of the presentation will be availabl

  • Motley Fool

    Ocugen, Inc. (OCGN) Q2 2022 Earnings Call Transcript

    Joining me today are Ocugen's chairman and CEO and co-founder, Dr. Shankar Musunuri, who will provide a business update; and our chief accounting officer and senior vice president of finance, Jessica Crespo, who will provide more on our financial results. Earlier this morning, we issued a press release detailing business activity for Q2 2022.